Saliniquinone Derivatives, Saliniquinones G−I and Heraclemycin E, from the Marine Animal-Derived Nocardiopsis Aegyptia HDN19-252

Luning Zhou,Xuedong Chen,Chunxiao Sun,Yimin Chang,Xiaofei Huang,Tianjiao Zhu,Guojian Zhang,Qian Che,Dehai Li
DOI: https://doi.org/10.3390/md19100575
2021-01-01
Marine Drugs
Abstract:Four new anthraquinone derivatives, namely saliniquinones G−I (1–3) and heraclemycin E (4), were obtained from the Antarctic marine-derived actinomycete Nocardiopsis aegyptia HDN19-252, guided by the Global Natural Products Social (GNPS) molecular networking platform. Their structures, including absolute configurations, were elucidated by extensive NMR, MS, and ECD analyses. Compounds 1 and 2 showed promising inhibitory activity against six tested bacterial strains, including methicillin-resistant coagulase-negative staphylococci (MRCNS), with MIC values ranging from 3.1 to 12.5 μM.
What problem does this paper attempt to address?